Ten-year survival of esophageal cancer after an en-bloc esophagectomy

Journal of Surgical Oncology

Volumn 105, Issue 3, 2012, Pages 284-287

  Oezcelik, Arzu ^a   Kaiser, Gernot M ^a   Niebel, Wolfgang ^a   Sleyman, Christopher ^a   Treckmann, Juergen W ^a   Sotiropoulos, Georgios C ^a   Reinhardt, Renate ^a   Trarbach, Tanja ^b   Malamutmann, Eugen ^a   Paul, Andreas ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

esophageal cancer; esophagectomy; long term outcome; neoadjuvant therapy; survival

Indexed keywords

CISPLATIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DEATH; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HUMAN; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE RISK;

ADENOCARCINOMA; AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES;

EID: 84856278816     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.22096     Document Type: Article

References (14)

1. Hagen JA, DeMeester SR, Peters JH, et al. Curative resection for esophageal adenocarcinoma: Analysis of 100 en bloc esophagectomies. Ann Surg 2001; 234: 520-530 (discussion 521-530).
2. Enzinger PC, Mayer RJ,: Esophageal cancer. N Engl J Med 2003; 349: 2241-2252. (Pubitemid 37485141)
3. Peyre CG, Hagen JA, DeMeester SR, et al. The number of lymph nodes removed predicts survival in esophageal cancer: An international study on the impact of extent of surgical resection. Ann Surg 2008; 248: 549-5556.
4. Pennathur A, Luketich JD, Landreneau RJ, et al. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm. Ann Thorac Surg 2008; 85: 1930-1936 (discussion 1936-1937).
5. Donahue JM, Nichols FC, Li Z, et al. Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival. Ann Thorac Surg 2009; 87: 392-3398 (discussion 398-399).
6. Meguid RA, Hooker CM, Taylor JT, et al. Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer: Does the pattern of recurrence differ for patients with complete response and those with partial or no response? J Thorac Cardiovasc Surg 2009; 138: 1309-1317.
7. Rizk NP, Ishwaran H, Rice TW, et al. Optimum lymphadenectomy for esophageal cancer. Ann Surg 2010; 251: 46-50.
8. Lv J, Cao XF, Zhu B, et al. Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma. World J Gastroenterol 2009; 15: 4962-4968.
9. Korst RJ, Kansler AL, Port JL, et al. Downstaging of T or N predicts long-term survival after preoperative chemotherapy and radical resection for esophageal carcinoma. Ann Thorac Surg 2006; 82: 480-484 (discussion 484-485).
10. Reynolds JV, Muldoon C, Hollywood D, et al. Long-term outcomes following neoadjuvant chemoradiotherapy for esophageal cancer. Ann Surg 2007; 245: 707-716. (Pubitemid 46684100)
11. Mariette C, Piessen G, Triboulet JP,: Therapeutic strategies in oesophageal carcinoma: Role of surgery and other modalities. Lancet Oncol 2007; 8: 545-553. (Pubitemid 46813024)
12. Boone J, Livestro DP, Elias SG, et al. International survey on esophageal cancer: Part II staging and neoadjuvant therapy. Dis Esophagus 2009; 22: 203-210.
13. Allum WH, Stenning SP, Bancewicz J, et al. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol 2009; 27: 5062-5067.
14. Gockel I, Sultanov FS, Domeyer M, et al. [Surgical therapy for esophageal carcinoma: A prospective 20-year analysis]. Zentralbl Chir 2008; 133: 260-266.